21 – 30 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2011
-
Mark
Identification of a Danger-Associated Peptide From Apolipoprotein B100 (ApoBDS-1) That Triggers Innate Proatherogenic Responses
(
- Contribution to journal › Article
- 2010
-
Mark
Experter eniga om indikationer för behandling av njurartärstenos
(
- Contribution to journal › Article
- 2008
-
Mark
High 18F-FDG Uptake in synthetic aortic vascular grafts on PET/CT in symptomatic and asymptomatic patients
(
- Contribution to journal › Article
-
Mark
Heparan sulfate in perlecan promotes mouse atherosclerosis : Roles in lipid permeability, lipid retention, and smooth muscle cell proliferation
(
- Contribution to journal › Article
- 2007
-
Mark
Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions
(
- Contribution to journal › Article
- 2004
-
Mark
Increased Intimal Hyperplasia and Smooth Muscle Cell Proliferation in Transgenic Mice with Heparan Sulfate-Deficient Perlecan
(
- Contribution to journal › Article
-
Mark
CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions
(
- Contribution to journal › Article
- 2002
-
Mark
Fibronectin promotes cell cycle entry in smooth muscle cells in primary culture
(
- Contribution to journal › Article
-
Mark
Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins
(
- Contribution to journal › Article
- 2001
-
Mark
Perlecan inhibits smooth muscle cell adhesion to fibronectin : Role of heparan sulfate
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »